Quantum-Si Incorporated (NASDAQ: QSI) stock jumped 4.10% on Friday to $1.65 against a previous-day closing price of $1.59. With 0.63 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.91 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.6800 whereas the lowest price it dropped to was $1.5550. The 52-week range on QSI shows that it touched its highest point at $3.90 and its lowest point at $1.12 during that stretch. It currently has a 1-year price target of $1.50. Beta for the stock currently stands at 3.02.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of QSI was up-trending over the past week, with a rise of 16.20%, but this was up by 36.36% over a month. Three-month performance dropped to -18.32% while six-month performance rose 8.55%. The stock lost -45.18% in the past year, while it has lost -9.84% so far this year. A look at the trailing 12-month EPS for QSI yields -0.76 with Next year EPS estimates of -0.80. For the next quarter, that number is -0.17. This implies an EPS growth rate of 34.74% for this year and -29.03% for next year.
Float and Shares Shorts:
At present, 120.01 million QSI shares are outstanding with a float of 99.25 million shares on hand for trading. On Oct 30, 2023, short shares totaled 8.99 million, which was 6.34% higher than short shares on Sep 28, 2023. In addition to Dr. Jonathan M. Rothberg Ph.D. as the firm’s Founder & Executive Chairman, Mr. Jeffrey Alan Hawkins serves as its President, CEO & Director.
Through their ownership of 36.57% of QSI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 23.66% of QSI, in contrast to 18.67% held by mutual funds. Shares owned by individuals account for 13.31%. As the largest shareholder in QSI with 11.86% of the stake, ARK Investment Management LLC holds 14,448,217 shares worth 14,448,217. A second-largest stockholder of QSI, Nikko Asset Management Americas,, holds 8,532,917 shares, controlling over 7.01% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in QSI, holding 6,080,899 shares or 4.99% stake. With a 11.49% stake in QSI, the ARK Genomic Revolution ETF is the largest stakeholder. A total of 13,996,471 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.47% of QSI stock, is the second-largest Mutual Fund holder. It holds 3,012,870 shares valued at 3.62 million. iShares Russell 2000 ETF holds 1.89% of the stake in QSI, owning 2,302,954 shares worth 2.76 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for QSI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With QSI analysts setting a high price target of $1.50 and a low target of $1.50, the average target price over the next 12 months is $1.50. Based on these targets, QSI could drop -9.09% to reach the target high and fall by -9.09% to reach the target low. Reaching the average price target will result in a decline of -9.09% from current levels.
Summary of Insider Activity:
Insiders traded QSI stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 115,942 shares were bought while 0 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has risen to 2 over the past year. The total number of shares bought during that period was 392,070 while 690,000 shares were sold.